<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01120613</url>
  </required_header>
  <id_info>
    <org_study_id>10-015A</org_study_id>
    <nct_id>NCT01120613</nct_id>
  </id_info>
  <brief_title>Post Kidney Transplant Nocturnal Hypertension Prevalence and Management Study</brief_title>
  <official_title>Post Kidney Transplant Nocturnal Hypertension Prevalence and Management Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwell Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypertension (HTN) affects up to 75% of kidney transplant recipients and is associated with
      premature death. Nocturnal HTN is a common complication of ongoing essential HTN or a
      secondary cause of HTN. Both the non dipping of systolic blood pressure (SBP) at night time
      and the reverse dipping is associated with increased target organ damage and adverse
      cardiovascular outcomes and possibly allograft survival. Treatment of Nocturnal HTN is
      critical. Chronotherapy has been shown to be effective in halting progression in patients
      with diabetic nephropathy and chronic kidney disease. There is not enough data on prevalence
      and management of nocturnal HTN in transplant patients, which is the object of this study.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    primary investigator left institution; not enough patients
  </why_stopped>
  <start_date>April 2010</start_date>
  <primary_completion_date type="Anticipated">August 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent drop in mean SBP at night time compared to mean SBP at day time</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urine Microalbumin to creatinine ratio</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Glomerular filtration rate as measured by MDRD equation.</measure>
    <time_frame>2 months</time_frame>
    <description>Serum creatinine as a measure of kidney function will be measured at the begining and end of intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24 hour mean systolic Blood Pressure (SBP) Control</measure>
    <time_frame>2 months</time_frame>
    <description>Ambulatory Blood pressure monitoring at the end of intervention will be used to assess 24 hour ( day and nighttime) blood pressure control We hypothesize that night time dosing of medication ( chronotherapy) will not only improve nocturnal hypertension but also improve awake blood pressure and overall 24 hour average SBP control.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>chronotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients identified with Nocturnal Hypertension, will have one of the blood pressure medications switched from daytime dosing to nighttime dosing</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chronotherapy</intervention_name>
    <description>Patients identified with nocturnal hypertension while treated with blood pressure medications will have one medication switched from daytime to night time dosing in the following preference:
ACE or ARB
Calcium Channel Blockers
Alpha Blocker
Beta Blocker
If patient is on only one daytime BP medication, it will be switched to night time dosing. No dose adjustments will be made nor any new medications will be added. Only timing of BP medication will be changed.</description>
    <arm_group_label>chronotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Renal transplant more than 1 year ago and not on dialysis.

          2. Age between 18 years to 70 years.

          3. Known history of HTN on one or more anti-hypertensive medication.

          4. Stable anti-hypertensive regimen for past 2 months

          5. One of the anti-hypertensive regimen must include an ACE inhibitor, or an angiotensin
             receptor blocker, calcium channel blocker, alpha or beta blocker.

          6. Stable immunosuppressive regimen with no dose changes in past 3 months.

          7. No hospitalizations for previous 2 months

        Exclusion Criteria:

          1. Inability to consent

          2. History of falls

          3. Presence of AVF or AVG in both the arms

          4. Inability to follow up in renal transplant clinic.

          5. History of Atrial fibrillation.

          6. Pregnant Women

          7. Parkinson's Disease

          8. Severe orthostatic Hypotension

          9. Severe autonomic dysfunction

         10. History of other transplanted organs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rajiv Vij, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>North Shore Long Island Jewish Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenar Jhaveri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>North Shore Long Island Jewish Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>North Shore Long Island Jewish Hospital</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11020</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Paoletti E, Gherzi M, Amidone M, Massarino F, Cannella G. Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring. Transplantation. 2009 Jun 27;87(12):1864-9. doi: 10.1097/TP.0b013e3181a76775.</citation>
    <PMID>19543066</PMID>
  </reference>
  <reference>
    <citation>Paoletti E, Bellino D, Amidone M, Rolla D, Cannella G. Relationship between arterial hypertension and renal damage in chronic kidney disease: insights from ABPM. J Nephrol. 2006 Nov-Dec;19(6):778-82.</citation>
    <PMID>17173252</PMID>
  </reference>
  <reference>
    <citation>McGlothan KR, Wyatt RJ, Ault BH, Hastings MC, Rogers T, DiSessa T, Jones DP. Predominance of nocturnal hypertension in pediatric renal allograft recipients. Pediatr Transplant. 2006 Aug;10(5):558-64.</citation>
    <PMID>16856991</PMID>
  </reference>
  <reference>
    <citation>Stenehjem AE, Gudmundsdottir H, Os I. Office blood pressure measurements overestimate blood pressure control in renal transplant patients. Blood Press Monit. 2006 Jun;11(3):125-33.</citation>
    <PMID>16702821</PMID>
  </reference>
  <reference>
    <citation>Oliveras A, V치zquez S, Hurtado S, Vila J, Puig JM, Lloveras J. Ambulatory blood pressure monitoring in renal transplant patients: modifiable parameters after active antihypertensive treatment. Transplant Proc. 2004 Jun;36(5):1352-4.</citation>
    <PMID>15251330</PMID>
  </reference>
  <reference>
    <citation>Covic A, Segall L, Goldsmith DJ. Ambulatory blood pressure monitoring in renal transplantation: should ABPM be routinely performed in renal transplant patients? Transplantation. 2003 Dec 15;76(11):1640-2.</citation>
    <PMID>14702541</PMID>
  </reference>
  <reference>
    <citation>Toprak A, Koc M, Tezcan H, Ozener IC, Oktay A, Akoglu E. Night-time blood pressure load is associated with higher left ventricular mass index in renal transplant recipients. J Hum Hypertens. 2003 Apr;17(4):239-44.</citation>
    <PMID>12692568</PMID>
  </reference>
  <reference>
    <citation>Hermida RC, Ayala DE. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension. 2009 Jul;54(1):40-6. doi: 10.1161/HYPERTENSIONAHA.109.130203. Epub 2009 May 11.</citation>
    <PMID>19433778</PMID>
  </reference>
  <reference>
    <citation>Hermida RC, Ayala DE, Fern치ndez JR, Calvo C. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension. 2008 Jan;51(1):69-76. Epub 2007 Oct 29.</citation>
    <PMID>17968001</PMID>
  </reference>
  <reference>
    <citation>Hermida RC, Ayala DE, Moj칩n A, Fern치ndez JR. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am J Hypertens. 2008 Aug;21(8):948-54. doi: 10.1038/ajh.2008.216. Epub 2008 Jul 3.</citation>
    <PMID>18600215</PMID>
  </reference>
  <reference>
    <citation>Hermida RC, Calvo C, Ayala DE, L칩pez JE, Rodr칤guez M, Chay치n L, Moj칩n A, Fontao MJ, Fern치ndez JR. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects. Chronobiol Int. 2007;24(3):471-93.</citation>
    <PMID>17612946</PMID>
  </reference>
  <reference>
    <citation>Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Am J Kidney Dis. 2007 Dec;50(6):908-17.</citation>
    <PMID>18037091</PMID>
  </reference>
  <reference>
    <citation>Vij R, Peixoto AJ. Management of nocturnal hypertension. Expert Rev Cardiovasc Ther. 2009 Jun;7(6):607-18. doi: 10.1586/erc.09.42. Review.</citation>
    <PMID>19505276</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2010</study_first_submitted>
  <study_first_submitted_qc>May 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2010</study_first_posted>
  <last_update_submitted>May 29, 2013</last_update_submitted>
  <last_update_submitted_qc>May 29, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2013</last_update_posted>
  <responsible_party>
    <name_title>Rajiv Vij MD MPH</name_title>
    <organization>North Shore LIJ</organization>
  </responsible_party>
  <keyword>Nocturnal Hypertension</keyword>
  <keyword>Nondipping</keyword>
  <keyword>Renal Transplant</keyword>
  <keyword>Chronotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

